6Dano K, Andreason PA, Grondahl-Hasen, et al. Plasminogen activitor, tissue degradation and cancer[J]. Adv Cancer Res,1985, 44:139.
7Bouchet C, Spyrators F, Martis PM, et al. Prognostic value of urokinase-type plasminogen activator and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas[J], Br J Cancer, 1994,199:179.
8Del Vecchio S, Stoppeli MP, Carriero MV, et al. Human urokinase receptor concentration in malign and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels[J]. Cancer Res, 1993,53 : 3198.
9Pedersen H, Grondahl-Hansen J, Francis D, et al. Urokinase and plasminogen activator inhibitor type-1 in pulmonary adenocarcinoma[J]. Cancer Res, 1994,54 : 120.
10Grondahl-Hansen J, Christensen I, Rosenquist C,et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis[J]. Cancer Res, 1993,53 ;2513.
